Cargando…

P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS

Detalles Bibliográficos
Autores principales: Miguel, Enrique Maria Ocio San, Efebera, Yvonne A., Hájek, Roman, Straub, Jan, Maisnar, Vladimir, Eveillard, Jean-Richard, Karlin, Lionel, Mateos, Maria-Victoria, Oriol, Albert, Ribrag, Vincent, Richardson, Paul, Norin, Stefan, Obermüller, Jakob, Bakker, Nicolaas A., Pour, Ludek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431071/
http://dx.doi.org/10.1097/01.HS9.0000970408.28426.27
_version_ 1785091112438857728
author Miguel, Enrique Maria Ocio San
Efebera, Yvonne A.
Hájek, Roman
Straub, Jan
Maisnar, Vladimir
Eveillard, Jean-Richard
Karlin, Lionel
Mateos, Maria-Victoria
Oriol, Albert
Ribrag, Vincent
Richardson, Paul
Norin, Stefan
Obermüller, Jakob
Bakker, Nicolaas A.
Pour, Ludek
author_facet Miguel, Enrique Maria Ocio San
Efebera, Yvonne A.
Hájek, Roman
Straub, Jan
Maisnar, Vladimir
Eveillard, Jean-Richard
Karlin, Lionel
Mateos, Maria-Victoria
Oriol, Albert
Ribrag, Vincent
Richardson, Paul
Norin, Stefan
Obermüller, Jakob
Bakker, Nicolaas A.
Pour, Ludek
author_sort Miguel, Enrique Maria Ocio San
collection PubMed
description
format Online
Article
Text
id pubmed-10431071
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310712023-08-17 P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS Miguel, Enrique Maria Ocio San Efebera, Yvonne A. Hájek, Roman Straub, Jan Maisnar, Vladimir Eveillard, Jean-Richard Karlin, Lionel Mateos, Maria-Victoria Oriol, Albert Ribrag, Vincent Richardson, Paul Norin, Stefan Obermüller, Jakob Bakker, Nicolaas A. Pour, Ludek Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431071/ http://dx.doi.org/10.1097/01.HS9.0000970408.28426.27 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Miguel, Enrique Maria Ocio San
Efebera, Yvonne A.
Hájek, Roman
Straub, Jan
Maisnar, Vladimir
Eveillard, Jean-Richard
Karlin, Lionel
Mateos, Maria-Victoria
Oriol, Albert
Ribrag, Vincent
Richardson, Paul
Norin, Stefan
Obermüller, Jakob
Bakker, Nicolaas A.
Pour, Ludek
P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title_full P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title_fullStr P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title_full_unstemmed P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title_short P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS
title_sort p876: anchor (op-104): melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma—final efficacy and safety results
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431071/
http://dx.doi.org/10.1097/01.HS9.0000970408.28426.27
work_keys_str_mv AT miguelenriquemariaociosan p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT efeberayvonnea p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT hajekroman p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT straubjan p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT maisnarvladimir p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT eveillardjeanrichard p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT karlinlionel p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT mateosmariavictoria p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT oriolalbert p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT ribragvincent p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT richardsonpaul p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT norinstefan p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT obermullerjakob p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT bakkernicolaasa p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults
AT pourludek p876anchorop104melflufenplusdexamethasoneanddaratumumaborbortezomibinrelapsedrefractorymultiplemyelomafinalefficacyandsafetyresults